The MED Project is a collaboration of state Medicaid agencies giving state policymakers the resources they need to make the best evidence-based decisions for improving health outcomes. MED reports and other tools provide valuable evidence about effective interventions and information about harmful or unnecessary services. MED participants meet regularly to discuss shared issues and have access to a wide-ranging collection of policy tools and evidence resources.
MED reports use robust research strategies to appropriately cover clinical, policy, and financial issues. While most reports are proprietary and available to members only through the MED Clearinghouse, the Center occasionally makes reports public.
MED members meet regularly to review report findings and discuss implementation issues. Members also collaborate through workgroups that address focused areas such as genetic testing.
The Center is seeking to obtain a consultant with experience and knowledge of genetic testing and the coverage of genetic tests as applied in the clinical setting. The candidate should have experience working with Medicaid, commercial insurers, or at a minimum with state agency decision makers. The consultant would be asked to:
Assist in reviewing research studies, systematic reviews and clinical practice guidelines on topics related to genetic testing and help prepare or write sections of MED reports at the request of MED participants
Serve as a subject matter expert to the MED genetic testing workgroup, Center research staff and members of the MED collaborative.
Attend and occasionally do formal presentations to the workgroup. The MED Genetic testing workgroup meets 4 times a year. Meetings take place on Thursdays from 11:00 am to 12:30 pm Pacific time.
Assist on other genetics related research the Center may conduct for clients in addition to those undertaken by the MED collaborative.
Examples of reports the Center has prepared for the MED collaborative on genetic testing related issues include:
Noninvasive Prenatal Testing Panels for Microdeletion Syndromes: Evidence, Guidelines, and Policies (2018)
Genomic Sequencing Panels for Hereditary Peripheral Neuropathies: Clinical Validity and Utility, Policies, and Reimbursement (2018)
Genetic Testing: State Approaches to Determining Medical Necessity and Prior Authorization Criteria (2021)
Whole Exome Sequencing: Evidence, Payer Policies, and Clinical Practice Guidelines (2022)
We plan to contract for services on an hourly basis. We expect the consultant would work from between 50 and 100 hours in a year.
For more information, please contact Allison Leof (email@example.com).
About the Center for Evidence-based Policy
The Center was established in 2003 and is based at Oregon Health & Science University in Portland, Oregon. The Center is recognized as a national leader in evidence-based decision making and policy design. We support public organizations by providing reliable information and opportunities for collaboration to guide decisions and improve health outcomes. The Center is nonpartisan, does not engage in lobbying, and our staff have no financial conflicts of interest.